OptimizeRx Corporation (NASDAQ:OPRX) Q1 2025 Earnings Call Transcript May 12, 2025
OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.08, expectations were $-0.11.
Operator: Good afternoon, everyone, and thank you for joining OptimizeRx First Quarter Fiscal 2025 Earnings Conference Call. With us today is Chief Executive Officer, Steve Silvestro, he’s joined by Chief Financial Officer; Ed Stelmakh; Chief Legal Officer, Marion Odence-Ford; and Senior Vice President of...
